Formula 1 (Papaverine 1.8 mg, Phentolamine 0.2 mg, Atropine 0.02 mg, PGE 18 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.
Published April 13, 2016 · Recall initiated: March 14, 2016
Summary
FDA records drug Class II recall D-0805-2016, published April 13, 2016 and initiated March 14, 2016. Recalling firm: Meditech Laboratories, Inc; Status: Terminated; Reported quantity: 1320 vials - all formulas; Lot: Lot#: 011916-1, Exp 04/19/16; 020316-1, Exp 05/03/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Meditech Laboratories, Inc
- Distributor
- Nationwide
- Lot
- Lot#: 011916-1, Exp 04/19/16; 020316-1, Exp 05/03/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFormula 0 (PGE 20 mcg/mL) Injection, 5 mL vials, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave.,April 13, 2016
- FDAFormula 4 (Papaverine 18 mg, Phentolamine 2 mg, Atropine 0.2 mg/mL) Injection, 5 mL vials, Rx only, MeditechApril 13, 2016
- FDAFormula 9 (Papaverine 0.9 mg, Phentolamine 0.1 mg, Atropine 0.01 mg, PGE 20 mcg/mL) Injection, 5 mL vial, RxApril 13, 2016
- FDAFormula 3 (Papaverine 20 mg, Phentolamine 3 mg, Atropine 0.2 mg, PGE 20 mcg/mL) Injection, 5 mL vials, RxApril 13, 2016
- FDAVP-CH-PNV PRENATAL/POSTNATAL Prescription Folic Acid-Containing Dietary Supplement, 30-count Softgel bottles,April 13, 2016
- FDARanitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5 mL), 16 fl oz Bottle, Rx only, Mfd For:April 13, 2016
Questions about this recall
Was Formula 1 (Papaverine 1.8 mg, Phentolamine 0.2 mg, Atropine 0.02 mg, PGE 18 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102. recalled?
Yes. FDA published recall D-0805-2016 on April 13, 2016. Reported hazard: Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit